Analiza, Inc. is a prominent contract research organization specializing in the life sciences sector, particularly in the pharmaceutical, biotechnology, and diagnostics industries. The company focuses on providing integrated solutions for measuring physicochemical properties and conducting in-vitro ADME (Absorption, Distribution, Metabolism, and Excretion) studies. Analiza emphasizes a fast turnaround for data delivery, typically within five business days, and offers flexible options for experimental protocols, allowing clients to either use standard methods or customize their own. This adaptability caters to a diverse range of budgets, making their services accessible to various clients.

In addition to their core services, Analiza is committed to advancing new technologies that support drug development and commercialization. Their expertise in physicochemical property measurement and custom analytical services positions them as industry leaders, capable of addressing the evolving needs of their clients. The company also engages in thought leadership through articles and insights on trends in the pharmaceutical industry, showcasing their knowledge and commitment to innovation in drug targeting and analysis techniques.

United States

Founded in 1996 in Cleveland, OH, Analiza, Inc. is a leading US based provider of high quality, affordable analytical services for physicochemical and ADME properties for early drug discovery markets. Adapting gold standard methods for compatibility with early drug discovery (throughput, sample requirements, turnaround time, and cost), Analiza developed the first automated, miniaturized, shake flask system for LogD in 1999. Since 2005, Analiza has provided over 150,000 solubility measurements, 45,000 LogD measurements and 2,500 pKa measurements. Analiza extends the in-house physchem and ADME profiling capabilities of small and large pharma and biotech alike.

Analiza

Company Details